4 Monitoring Questions Before Starting Fezolinetant for Hot Flashes

The laboratory schedule belongs in the conversation before the first tablet.

Four questions for the prescribing visit

1. Have my health history and medicines been checked? The label lists cirrhosis, severe kidney impairment or end-stage kidney disease, and use with certain interacting medicines called CYP1A2 inhibitors as contraindications. Bring a complete medicine and supplement list for review.¹

2. Are my starting liver tests acceptable? Tests are required before treatment begins. Elevated results can mean the medicine should not be started. Ask who will review the results before you take the first dose.¹

3. Which dates need follow-up tests? The schedule is monthly for the first three months, then at months six and nine. Additional testing may be needed for symptoms or abnormal results. Ask who orders each test and how you’ll receive the result.²¹

4. What symptoms mean I should stop and call? The FDA² says to stop Veozah immediately and contact the prescriber for possible liver-injury symptoms. These include unusual fatigue, nausea or vomiting, itching, yellow eyes or skin, pale stools, dark urine or abdominal pain. Don’t wait for the next scheduled test.²

Keep the monitoring plan with the prescription

Record the start date, test dates and clinic contact. Ask what to do if you cannot attend a planned blood test. Read the patient leaflet each time the prescription is filled; the FDA² advises this because safety information may change.²

The FDA² describes serious liver injury as rare but says it cannot determine an individual’s likelihood of experiencing it. Discuss benefits and risks for your circumstances.²

My Body Changed. Now What? lists a symptom diary and Visit Brief in its toolkit. Those pages can organize hot-flash changes and questions for your prescriber. See the book.